AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7154707
Drug: Fractionated daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractionated daily injections (0.5 mg/m2 i.v. q.12 h X 10, course to be repeated after 10‐15 days)
Trial: 21934629
Drug: Fimasartan (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fimasartan (240 mg) with Hydrochlorothiazide (HCTZ, 25 mg)
Trial: 21934629
Drug: Hydrochlorothiazide (HCTZ,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ, 25 mg) with Fimasartan (240 mg)
Trial: 17244766
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg single dose)
Trial: 9537487
Drug: Separate injection
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate injection of DTaP and commercial Hib vaccine
Trial: 9537487
Drug: Booster doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster doses (separate or mixed injections of Hib and DTaP vaccines)
Trial: 7702021
Drug: Low-resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-resistant starch (RS) diet (5.2 +/‐ 0.4 g RS)
Trial: 28891423
Drug: Ipilimumab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipilimumab (10 mg/kg every 3 weeks for four doses, then every 12 weeks)
Trial: 7799590
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for bile duct fistula
Trial: 3259889
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of propofol with repeated bolus doses of alfentanil (group III)
Trial: 28716357
Drug: 1000mg omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000mg omega-3 fatty acids from flaxseed oil supplements, twice a day for 12 weeks
Trial: 25193672
Drug: Ranibizumab treatment
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab treatment
Trial: 16607544
Drug: Radioiodine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine therapy without carbimazole
Trial: 9206240
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CG) - Nifedipine tablet
Trial: 26890759
Drug: LC-n3-FA (2,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC-n3-FA (2,200 mg/day, n=22)
Trial: 7519977
Drug: Buprenorphine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (2 mg/day and 6 mg/day)
Trial: 2500941
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of insulin in class B-F diabetic patients
Trial: 2500941
Drug: Corticosteroids administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Corticosteroids administration to the mother
Trial: 31648515
Drug: Ultrasound-guided quadratus
RxNorm normalized name: Pisum quadratum whole
DrugBank: Pisum sativum whole (DB15545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided quadratus lumborum (QL) block using 0.25% bupivacaine solution (0.5 ml kg−1)
Trial: 31648515
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural block using 0.25% bupivacaine solution (0.5 ml kg−1)
Trial: 27439031
Drug: Montelukast (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (4 or 5 mg daily for 16 weeks)
Trial: 22735866
Drug: Metoprolol IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol IV 5‐15 mg or up to HR ≤ 60 bpm (M)
Trial: 22735866
Drug: Diltiazem IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem IV 0.25 to 0.60 mg/kg or up to HR ≤ 60 bpm (D)
Trial: 11289345
Drug: Micronised fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronised fenofibrate (200 mg/day)
Trial: 12474116
Drug: Tandospirone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tandospirone (60 mg)
Trial: 30632208
Drug: Dornase alfa
RxNorm normalized name: Dornase Alfa
DrugBank: Dornase alfa (DB00003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dornase alfa (2.5 ml, nebulized once daily for 1 month)
Trial: 30632208
Drug: Control (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (5 ml of isotonic saline, nebulized once daily for 1 month)
Trial: 9579258
Drug: Intravenous tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tenoxicam (20 mg) administered 30 min before surgery
Trial: 9579258
Drug: Intravenous tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tenoxicam (20 mg) administered after incision
Trial: 23297711
Drug: Valsartan (80-320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (80-320 mg/day)
Trial: 19799201
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (LPD) with essential keto/amino acids (0.6 g/kg/day) for 24-48 months
Trial: 19799201
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (LPD) with highly purified soya protein (0.3 g/kg/day) in a highly energetic nutrient mixture for 24-48 months
Trial: 16473754
Drug: Practitioner assessment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practitioner assessment of treatment (Sham moxibustion)
Trial: 16473754
Drug: Practitioner assessment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practitioner assessment of treatment (Undisclosed treatment)
Trial: 10954887
Drug: Nucleoside analogue
RxNorm normalized name: Nucleoside analogue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nucleoside analogue reverse transcriptase inhibitors
Trial: 3544187
Drug: H2-receptor antagonist
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-receptor antagonist cimetidine (Tagamet, 200 mg three times daily and 400 mg/day)
Trial: 3544187
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (antacid and cimetidine)
Trial: 30355453
Drug: Trifluridine/tipiracil (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trifluridine/tipiracil (35 mg/m2 twice daily on days 1-5 and days 8-12 every 28 days) plus best supportive care
Trial: 24871703
Drug: Oxytocin (OXT)
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin (OXT) administration
Trial: 20979731
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (similar treatment without trimetazidine)
Trial: 18832293
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of tibolone (2.5 mg)
Trial: 18832293
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of tibolone (2.5 mg)
Trial: 6298047
Drug: One shot
RxNorm normalized name: Acetaminophen 650 mg in 50 mL ORAL LIQUID [Headache Man No More Pills, One Shot, Headache Pain Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One shot therapy (One shot group)
Trial: 30628950
Drug: Hydrocortisone bolus
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone bolus (50 mg every 6 hours)
Trial: 19754498
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care in two internal medicine services (UC).
Trial: 7836522
Drug: Intracytoplasmic sperm
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic sperm injection (ICSI) using epididymal or testicular spermatozoa
Trial: 28688129
Drug: Grazoprevir 100
RxNorm normalized name: grazoprevir 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grazoprevir 100 mg, ruzasvir 60 mg, and uprifosbuvir 450 mg plus ribavirin for 16 weeks (C‐CREST Part C)
Trial: 23008337
Drug: Volunteers for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volunteers for treatment (n = 161)
Trial: 11044005
Drug: Oral predictive
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral predictive thermometer
Trial: 11044005
Drug: Oral glass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glass mercury thermometer
Trial: 8867395
Drug: HRT (hormonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT (hormonal replacement therapy)
Trial: 8867395
Drug: Non-HRT (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-HRT (no hormone regimen)
Trial: 6734056
Drug: 15-mg quazepam
RxNorm normalized name: quazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-mg quazepam tablet in the morning after a night's sleep
Trial: 3026039
Drug: Ca-gluconate (1.58
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ca-gluconate (1.58 g Ca)
Trial: 3026039
Drug: Ossopan (osseino-mineral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ossopan (osseino-mineral complex, 1.58 g Ca)
Trial: 3026039
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of 24-hour urine excretion
Trial: 29055155
Drug: apremilast 30
RxNorm normalized name: apremilast 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: apremilast 30 mg bid
Trial: 26645588
Drug: Mipomersen (50-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen (50-400 mg, administered subcutaneously or via a 2-h intravenous infusion)
Trial: 26645588
Drug: Mipomersen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen (200 mg IV)
Trial: 26645588
Drug: Moxifloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (400 mg IV)
Trial: 20838622
Drug: High-dose folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose folic acid (0.8 mg/d), vitamin B12 (0.5 mg/d), and vitamin B6 (20 mg/d) for 24 months
Trial: 20838622
Drug: High-dose B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose B vitamins
Trial: 12915827
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 to 20 mg)
Trial: 2060564
Drug: Caffeine 4.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 4.2 mg.kg‐1.day‐1
Trial: 3178924
Drug: Midazolam 15
RxNorm normalized name: midazolam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 15 mg
Trial: 21807137
Drug: NSAID (ibuprofen)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: NSAID (ibuprofen)
Trial: 30368796
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of honey
Trial: 30368796
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of marmalade (Control)
Trial: 30368796
Drug: Honey vs
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey vs Glucose solution
Trial: 20075644
Drug: 16-mg ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16-mg ER hydromorphone
Trial: 20075644
Drug: 32-mg ER
RxNorm normalized name: triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 32-mg ER hydromorphone
Trial: 20075644
Drug: 64-mg ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 64-mg ER hydromorphone
Trial: 20075644
Drug: 8-mg IR
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-mg IR hydromorphone
Trial: 20075644
Drug: 8-mg ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-mg ER hydromorphone (milled)
Trial: 2241001
Drug: Trimetazidine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (60 mg/day)
Trial: 9716159
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg rHDL/kg body weight
Trial: 9716159
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg rHDL/kg body weight
Trial: 8480959
Drug: Lovastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (20 to 80 mg/d)
Trial: 29273578
Drug: Dasiglucagon 0.6
RxNorm normalized name: DASIGLUCAGON 0.6MG/0.6ML AUTOINJECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasiglucagon 0.6 mg
Trial: 25063211
Drug: SD-FBP (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SD-FBP (standard dose, 120 kV, 6 ± 1 mGy)
Trial: 20080983
Drug: Modafinil, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil, 400 mg
Trial: 16796223
Drug: Caffeine, 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine, 600 mg
Trial: 14671195
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg exemestane daily for 10 days
Trial: 8792690
Drug: 10 MU
RxNorm normalized name: saliva substitute comb no.10 MUCOUS MEM POWDER IN PACKET (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 MU of interferon-alpha 2b (IFN-alpha), three times weekly for 6 months (group A)
Trial: 8792690
Drug: 3 MU
RxNorm normalized name: Orasep Reformulated Dec 2013 Mucosal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 MU of interferon-alpha 2b (IFN-alpha), three times weekly for 6 months (group B)
Trial: 17368645
Drug: Lactated Ringer
RxNorm normalized name: lactated ringers
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer solution
Trial: 15876453
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control - CO)
Trial: 24107880
Drug: Pantocalcin (hopantenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantocalcin (hopantenic acid preparation)
Trial: 10759359
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 250 mg bid
Trial: 10759359
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 50,000 IU given in three divided doses
Trial: 1295136
Drug: Amodiaquine therapy
RxNorm normalized name: Amodiaquine
DrugBank: Amodiaquine (DB00613)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amodiaquine therapy (25 mg base/kg over 3 days)
Trial: 21198234
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of transference work
Trial: 12140795
Drug: RC-Cornet(R) therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RC-Cornet(R) therapy group (combined-PEP therapy)
Trial: 12140795
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy group (theophylline, salmeterol, ipratropiumbromide, systemic steroids)
Trial: 10430331
Drug: Methotrexate 15
RxNorm normalized name: methotrexate 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate 15 mg/week, adjusted up to 22.5 mg/week
Trial: 2250563
Drug: Salmon calcitonin
RxNorm normalized name: Salmon calcitonin
DrugBank: Salmon calcitonin (DB00017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmon calcitonin (CT) 100 UI administered by nasal route
Trial: 31596127
Drug: Artificial pancreas
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial pancreas with learning algorithm (daily updates of basal rates and carbohydrate ratios)
Trial: 10778882
Drug: Test diet
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test diet with soy protein foods (33 g/d soy protein)
Trial: 7870896
Drug: Desipramine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine (75 mg daily)
Trial: 3530865
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg at bedtime for 6 months)
Trial: 3530865
Drug: Ranitidine (open
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (open treatment)
Trial: 17398320
Drug: Placebo (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (no adjuvant therapy)
Trial: 26308112
Drug: Groups 1-4
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Groups 1-4 (concomitant administration)
Trial: 26308112
Drug: Concomitant administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concomitant administration of Vaqta, PedvaxHIB, and Infanrix
Trial: 26308112
Drug: Concomitant administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concomitant administration
Trial: 25473191
Drug: Lubiprostone (Amitza),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubiprostone (Amitza), orally twice a day for six days
Trial: 11126207
Drug: Orlistat treatment
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orlistat treatment
Trial: 11952580
Drug: Interferon-alpha therapy
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha therapy (6 MIU intramuscularly every day for 2 weeks, then three times a week for 14 weeks and finally twice a week for 88 weeks)
Trial: 7698517
Drug: Glipizide (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide (2.5 mg/day)
Trial: 2744191
Drug: Wallace catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wallace catheter (H.G. Wallace Limited, Colchester, England)
Trial: 23305820
Drug: 12-step facilitation
RxNorm normalized name: STEP 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-step facilitation for stimulant abusers
Trial: 21969930
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate 250 mcg twice daily for four weeks
Trial: 21969930
Drug: Open-label treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label treatment with fluticasone propionate 250 mcg/salmeterol 50 mcg
Trial: 18524134
Drug: Hydroxyethyl starch
RxNorm normalized name: Hydroxyethyl starch
DrugBank: Hydroxyethyl Starch (DB09106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl starch (HES) solutions (light, medium, heavy molecular weight)
Trial: 10443327
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin injected 5 minutes before meals
Trial: 10443327
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin injected 30 minutes before meals
Trial: 760446
Drug: Continuous heparin
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous heparin therapy
Trial: 760446
Drug: Intermittent heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent heparin therapy
Trial: 760446
Drug: Overall group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall group (both therapies)
Trial: 22065255
Drug: SMM plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SMM plus opioid dependence counseling during extended treatment
Trial: 9864127
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (LR) with Morgan therapeutic lens (MTL)
Trial: 9864127
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (LR) without Morgan therapeutic lens (MTL)
Trial: 9864127
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution (BSS Plus) without Morgan therapeutic lens (MTL)
Trial: 9864127
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (NSS) without Morgan therapeutic lens (MTL)
Trial: 9864127
Drug: Ocular irrigation
RxNorm normalized name: Sodium chloride 9 mg/mL solution for ocular irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ocular irrigation solutions (LR, BSS Plus, NSS)
Trial: 8919570
Drug: Colorectal cancer
RxNorm normalized name: Cancer/testis antigen 1
DrugBank: Cancer/testis antigen 1 (DB19291)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colorectal cancer screening (various modalities); specific details on dosage and duration not available.
Trial: 2191990
Drug: Inhaled bitolterol
RxNorm normalized name: bitolterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled bitolterol (three puffs, 1110 micrograms)
Trial: 11279374
Drug: NaCl 5
RxNorm normalized name: NaCl 5 MG/ML Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl 5 ml (Control Group F)
Trial: 8193000
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of patch vs primary closure
Trial: 28225446
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (CT) alone
Trial: 19244043
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and radiation therapy (CRT)
Trial: 27084997
Drug: Udenafil 100
RxNorm normalized name: udenafil
DrugBank: Udenafil (DB06267)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Udenafil 100 mg in healthy subjects